Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances
Jing Yu, Chao Zhang, Chunshan Song
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114516-114516
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 17
Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
Samarpan Maiti, Didier Picard
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1166-1166
Open Access | Times Cited: 42
Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities
Jaka Dernovšek, Tihomir Tomašič
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108396-108396
Open Access | Times Cited: 19
Design, Synthesis, and Biological Evaluation of Chiral-Proline Derivatives as Novel HSP90 Inhibitors
Chao Zhang, Shuang Cui, J. Mu, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
A Review on Gold Nanoclusters for Cancer Phototherapy
Zhuoren Yang, Xiebingqing Yang, Yahui Guo, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 11, pp. 4504-4517
Closed Access | Times Cited: 17
Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress
Yajun Liu, Chenyao Li, Hongwei Liu, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 5, pp. 442-464
Closed Access | Times Cited: 5
New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer
Živa Zajec, Jaka Dernovšek, Jernej Cingl, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12984-13018
Open Access | Times Cited: 5
Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design
Marius Gedgaudas, Paulina Kaziukonytė, Visvaldas Kairys, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116505-116505
Closed Access | Times Cited: 4
Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
Stefan Tukaj, Krzysztof Sitko
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1153-1153
Open Access | Times Cited: 25
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
Xinqi Liang, Ruixian Chen, Chengdi Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 15968-15995
Closed Access | Times Cited: 3
Pharmacophore Model-Based Virtual Screening Workflow for Discovery of Inhibitors Targeting Plasmodium falciparum Hsp90
Ofentse Mafethe, Tlhalefo Ntseane, Tendamudzimu Harmfree Dongola, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38220-38232
Open Access | Times Cited: 8
XQZ3, a Chlorella pyrenoidosa polysaccharide suppresses cancer progression by restraining mitochondrial bioenergetics via HSP90/AKT signaling pathway
Long Sun, Meng Ji, Yulin Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130705-130705
Closed Access | Times Cited: 1
Design and Synthesis of Novel 6,7‐Dihydrobenzo[d]isoxazol‐4(5H)‐one Derivatives Bearing 1,2,3‐Triazole Moiety as Potential Hsp90 Inhibitors and their Evaluation as Antiproliferative Agents
Nastassia A. Varabyeva, Diana I. Salnikova, Stepan K. Krymov, et al.
ChemistrySelect (2024) Vol. 9, Iss. 12
Closed Access | Times Cited: 1
Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction
Lisha Wang, Rajnish Kumar, Bengt Winblad, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116356-116356
Open Access | Times Cited: 1
Synthesis and Antiproliferative Effect of New Alkyne-Tethered Vindoline Hybrids Containing Pharmacophoric Fragments
Etelka Ferenczi, Péter Keglevich, Bizhar Ahmed Tayeb, et al.
(2024)
Open Access | Times Cited: 1
The Role of HSP90 Molecular Chaperones in Depression: Potential Mechanisms
Xuyuan Fan, Lei Sun, Ye Qin, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo
Jaka Dernovšek, Dunja Urbančič, Živa Zajec, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107850-107850
Open Access | Times Cited: 1
Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry
Russell R. A. Kitson, Dominika Kitsonová, David Siegel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 17946-17963
Open Access | Times Cited: 1
Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders
Jaka Dernovšek, Tjaša Goričan, Marius Gedgaudas, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116934-116934
Open Access | Times Cited: 1
Pan‐HSP90 ligand binding reveals isoform‐specific differences in plasticity and water networks
Timothy R. Stachowski, Stanley Nithianantham, Murugendra Vanarotti, et al.
Protein Science (2023) Vol. 32, Iss. 5
Open Access | Times Cited: 4
Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells
Chenyu Qiu, Xin Shen, Hui Lü, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia
Katja Seipel, Scarlett Kohler, Ulrike Bacher, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 9, pp. 7011-7026
Open Access | Times Cited: 3
A silicon-containing aryl/penta-1,4-dien-3-one/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without inducing heat-shock response
Yuting Liao, Xin-Ye Du, Mei Wang, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2625-2639
Closed Access | Times Cited: 3
Design, synthesis and biological evaluation of a new class of Hsp90 inhibitors vibsanin C derivatives
Meng Li, Xianlan She, Yufei Ou, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114844-114844
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top